SLC7A11 and B-cell chronic lymphocytic leukemia: The heterogeneous sensitivity of CLL cells measured with Annexin/PI assays towards PRIMA-1Met and SAS (Figure 4) can be ascribed to the expression of SLC7A11/xCT in different cell models.